药物诱导的精神疾病:药物监督更新
François Montastruc1, Tanguy Taillefer de Laportaliere2
1Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Toulouse University Hospital (CHU), Faculty of Medicine, 31000 Toulouse, France; CIC 1436, Team PEPSS (Pharmacologie En Population cohorteS et biobanqueS), Toulouse University Hospital, 31000 Toulouse, France.
概括
药物诱导的精神疾病,包括抑郁症,精神病和焦虑症,是关键的安全问题. 了解这些风险对于安全的临床实践至关重要,特别是在新药方面.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 药物诱导的精神疾病对某些药物来说是一个重大的临床挑战和局限性.
- 了解这些不良影响对于患者安全和有效的治疗策略至关重要.
研究的目的:
- 审查临床实践中遇到的有关药物诱导精神疾病的最新问题.
- 为了涵盖与药物使用相关的抑郁症,精神病和躁狂症以及焦虑和睡眠障碍.
主要方法:
- 这项研究是对最近文献和临床实践问题的非详尽审查.
- 它检查了与各种药物类相关的精神疾病,包括皮质类固醇,抗抑郁药和较新的药物.
主要成果:
- 通常审查的精神病风险包括抑郁,自杀念头,精神病,躁狂,焦虑和睡眠障碍.
- 方法上的挑战,例如根据指示进行混,使药物诱导的精神病影响的评估变得复杂.
- 新出现的担忧涉及诸如蒙特卢卡斯特,素受体对抗剂和囊性纤维化转膜调节器 (CFTR) 调节器等药物.
结论:
- 药物诱导的精神疾病需要在临床决策中仔细监测和考虑.
- 解决药监监中的方法差距对于准确识别和管理这些风险至关重要.
- 临床医生必须始终意识到与制药剂相关的既定和新兴的精神病风险.
相关概念视频
Pharmacovigilance
860
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
860
Psychosis and Antipsychotic Drugs: Overview
289
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
289
Psychosis: Goals of Pharmacotherapy
143
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
143
Drug Therapy
47
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
47
Mania and Antimanic Drugs: Overview
202
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
202
Diagnostic and Statistical Manual of Mental Disorders (DSM)
59
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
59


